About BSG

Bio-Signal Group’s (BSG) mission is to enable functional brain monitoring anywhere at any time, for everyone. Our initial solution is the microEEG™ System, a small, wireless, easy-to-use brain monitoring system designed specifically for use in the Emergency Department.

BSG was founded in 2002 by Dr. André Fenton to commercialize a proprietary digital telemetry (DT) technology. Since its founding, BSG has worked on developing new applications for DT, and in recognition of the strength of its technology and team, has been awarded multiple competitive NIH grants for developing DT technology for these applications. These include "Wireless Recording of Wideband Neuronal Activity in Freely Moving Humans" (NIH: R43NS057839-01) for intra-cranial EEG recordings and “Commercializing Digital Wireless Telemetry: The Animal Epilepsy Monitoring Unit” (NIH: R42NR009877-02A1). The microEEG™ System was the result of BSG’s efforts in another funded project, “First Responder EEG Device for Seizure Management in a Nerve-gas Attack” (NIH: U44NS057951-01) as part of NIH’s CounterACT Initiative. More recently BSG received a 3 year award to conduct clinical trials with the microEEG™ System in the Emergency Department (NIH: 1RC3NS070658-01). To date BSG has received over $5M in grant funding to commercialize its technology.

To support this mission, BSG has assembled a team of staff and collaborators with experience and know-how in neuroscience, emergency medicine, neurology, engineering, software development, product development, FDA regulations, reimbursement, the medical device industry, venture capital and law. BSG President, Dr. André Fenton is a Professor at the Center for Neural Science at New York University, and an internationally-recognized neuroscientist. His work was recognized by Science as one of the top 10 breakthroughs of 2006 in all of science, the only breakthrough in Neuroscience.

André Fenton (PhD)
President
André Fenton (PhD), a BSG founder and the President, is Professor of Neural Science at the Center for Neural Science at New York University. He is an internationally-recognized electrophysiologist trained in extracellular recording of brain activity from freely-moving rats. His research combines electrophysiological techniques with behavioral (Bures et al., 1998; Fenton et al., 1998), pharmacological (Cimadevilla et al., 2001), computational (Fenton and Muller, 1998; Olypher et al., 2002) and molecular biological (Pastalkova et al., 2006) methods to study the molecular basis of memory storage, and the organization and disorganization of cognitive representations in hippocampus. Recently, Dr. Fenton used BSG’s ITS (Interactive Tracking System) to identify PKMζ as the first molecular mechanism of long-term memory storage (Pastalkova et al., 2006). This work was recognized by Science as one of 10 major breakthroughs in 2006. During his former appointment at the Institute of Physiology in Prague, he co-invented an earlier digital telemetry technology from which the current microEEG™ system evolved.
John Gridley (M.P.P.)
CEO
John Gridley, a BSG founder and the CEO, became a full-time employee of the company in 2004. Mr. Gridley previously worked for 4 years as Finance and Business Development Director of an internet software start-up, Centrum Holdings BV, funded in part by Intel Capital’s venture fund. The company successfully exited to a private equity fund for a valuation reported in the press at over $150M in late 2007. Mr. Gridley was also previously employed by PricewaterhouseCoopers where he raised finance for early stage technology companies in Central Europe and was involved as a corporate finance advisor to multinational companies in several acquisitions in that region. Prior to this he worked as a staff member for the US House of Representatives Committee on Small Business. He graduated magna cum laude from Yale University in 1988 with degrees in history and classics (Latin) and received a master’s in public policy from the John F. Kennedy School of Government at Harvard University in 1994.
MORE BSG PROFILES
BSG News

October 2011   iMedicalApps reviews the microEEG™ System and calls it " . . . a truly impressive peripheral device . . ." (Link)


September 2011   BSG files FDA 510(k) Premarket Notification (application) for the microEEG™ System.


More BSG News


For scientific instruments go to research.biosignalgroup.com





BSG Facility in Brooklyn, NY